Ferabright Generic: When Will Generic Ferumoxytol Be Available?
This page is aggregated from FDA records, court filings and company announcements. Coded and designed by Dr. Brian Staiger, PharmD, BCPS
Updated October 9, 2026 How we build our data
Ferabright Generic at a Glance
Four quick answers from FDA records and our estimate.
- When is the first generic expected? October 2032 About 6 years away Why then?
- Has the FDA approved a generic? January 2021 1 company approved
- When does the last FDA protection end? October 2028 FDA exclusivity: new product
- Can you buy a generic today? Yes 1 company lists one
It already is. A generic ferumoxytol is listed for sale by 1 company, so ask your pharmacy whether it can fill your prescription with one.
Why October 2032?
FDA gives new drugs a protected period, for example for a rare-disease use. It ends then. We rate it probable: more likely than not, but it can still move.
What should I do now?
Ask your pharmacy whether it can fill your prescription with a generic. It may look different from Ferabright, but the active ingredient, strength and form are the same. What a generic means for you
Our month is only an estimate based on available information, so we never name a day.
Ferabright by the Numbers
- Reason
- FDA exclusivity endsFDA gives new drugs a protected period, for example for a rare-disease use. It ends then.
- How sure
- Probable More likely than not, but it can still move.
- Price competition
- None filed yet No filers on record
- Brand sales
- Sales not reported
- FDA approved 2025 October 2025 FDA Orange Book
- Patents listed 0 none listed FDA Orange Book
- Generics FDA-approved 1 company, approved January 2021 FDA Orange Book
Ferabright’s Road to a Generic
Ferabright has had the market to itself since the FDA approved it in October 2025 (Azurity Pharmaceuticals Inc). Its FDA protection (new product) runs to October 2028.
The first generic of Ferabright is expected in October 2032.
Why that month: FDA gives new drugs a protected period, for example for a rare-disease use. It ends then.
Each bar runs from the brand’s approval to the day that protection ends. The green band is our projection for the first generic: a month, never a day, because legal dates move and a generic reaches shelves days to weeks after it is allowed. Sources: FDA Orange Book; the expected month from court records and company announcements.
Ferabright Patents and FDA Protections
Every patent and exclusivity the FDA Orange Book lists for Ferabright’s own applications. A protection running past the expected month does not mean the date is wrong: a settlement or a court ruling can let a generic in before a patent ends, and a patent on one formulation or use does not block every generic.
| Exclusivity | What it means | Ends | Status |
|---|---|---|---|
| New product NP | Three years of protection for a change that needed new clinical studies. | October 2028 | Active |
Source: FDA Orange Book, application 219868. Patent numbers open the patent on Google Patents.
Who Is Lined Up to Make Generic Ferumoxytol
Three steps stand between a brand and a generic you can buy: a company applies to the FDA, the FDA approves it, and the company starts selling it.
Applied to the FDA
No application count is on record for Ferabright, but the FDA has already approved 1 company (step 2), and every approval starts with an application.
Approved by the FDA
The FDA has approved generic versions from 1 company, the first in January 2021. Approved is not the same as on sale: patents, a settlement or the company’s own plans can still hold a launch.
For Sale in Pharmacies
Yes. A generic ferumoxytol is listed for sale by 1 company. Ask your pharmacy whether it can fill your prescription with it.
Sandoz Inc
| Company | First approved | Strengths | Rated |
|---|---|---|---|
| Sandoz Inc | January 2021 | EQ 510MG IRON/17ML (EQ 30MG IRON/ML) | AB |
Sources: how many companies have applied, from court records and company announcements; approved generics from the FDA Orange Book; what is for sale from the FDA NDC Directory. The FDA does not disclose an application before it approves it (21 CFR 314.430).
Ferabright Price: What Pharmacies Pay and What Generics Usually Do
What a Generic Could Cost
How we estimate it. The national survey of what pharmacies pay (NADAC) has no recent price for Ferabright, so we cannot show dollars. Here is the FDA’s finding of how far the price pharmacies pay usually falls as generic companies join: about 31% with one company, 44% with two, 73% with four and over 95% with six or more (the typical drop for every drug whose first generic came out from 2015 to 2017).
Median prices pharmacies paid for the generic (invoice prices), compared with the brand’s price before generic entry, from FDA’s 2019 analysis “Generic Competition and Drug Prices”. At the manufacturer’s price FDA found steeper drops (about 39%, 54%, 79% and over 95%), the figures quoted elsewhere on this tracker. A typical pattern, not a price quote for this medicine.
Ferabright Strengths and Forms
| Strength | Form | How it is taken | Approved | Status |
|---|---|---|---|---|
| EQ 300MG IRON/10ML (EQ 30MG IRON/ML) | Solution | Intravenous | October 2025 | Prescription reference product |
| EQ 510MG IRON/17ML (EQ 30MG IRON/ML) | Solution | Intravenous | October 2025 | Prescription reference product |
Source: FDA Orange Book, Azurity Pharmaceuticals Inc. Listed for sale today by Azurity Pharmaceuticals, Inc. (FDA NDC Directory).
Ferabright NDC Codes and Packages
Each Ferabright package sold today has its own NDC, the product number printed on the box and on the pharmacy label. Open one to see that package’s details, what pharmacies pay for it and its patent timeline.
| NDC | Product | Package | Company |
|---|---|---|---|
| 24338-0310-10 | FERUMOXYTOL 30 mg/mL injection | vial of 10 mL | Azurity Pharmaceuticals, Inc. |
| 24338-0510-17 | FERUMOXYTOL 30 mg/mL injection | vial of 17 mL | Azurity Pharmaceuticals, Inc. |
Source: the FDA NDC Directory, current listings only. Only packages sold under Ferabright’s own FDA approval (NDA 219868) are listed, never a generic. Some codes belong to companies that repackage Ferabright: it is the same medicine in a different package.
What a Generic Ferabright Means for You
Nothing Changes Until It Is in Pharmacies
A generic is listed for sale now, so your pharmacy may already be able to fill your prescription with it.
Your Pharmacy May Switch You Automatically
Every state lets pharmacists fill a brand-name prescription with an FDA-approved generic rated as equivalent to it, and about 19 states require them to, unless your prescriber writes “dispense as written” or “brand medically necessary” on the prescription. Some states ask the pharmacist to tell you, or to get your OK first. A study of every state’s law has the details.
It Will Probably Look Different
US trademark law does not let a generic look exactly like the brand, so the color, shape or markings usually change. The active ingredient, strength and form are the same. An “authorized generic,” made by or for the brand’s own company, can look identical. The FDA explains.
Your Insurance May Change Too
Once a lower-cost version is available, many insurance plans charge more for the brand, or stop covering it. Your plan’s drug list (formulary) says how.
Questions people ask about Ferabright
Is there a generic for Ferabright right now?
Yes. The FDA NDC Directory lists a generic ferumoxytol from 1 company. Ask your pharmacy whether it can fill your prescription with it.
When will Ferabright go generic?
It already has. The FDA NDC Directory lists a generic ferumoxytol from 1 company, so ask your pharmacy whether it can fill your prescription with one.
Will generic ferumoxytol be the same as Ferabright?
Yes in the ways that matter: the same active ingredient, strength and form, with proof that it reaches your blood the same way. Inactive ingredients can differ, which is why some people notice a different look or taste.
How much will the generic cost?
Nobody can say for sure before launch. The FDA has already approved one company to make a generic, and how many of them launch decides how far the price falls.
Has the FDA approved a generic Ferabright?
Yes. The FDA Orange Book lists approved generic versions from 1 company, the first approved in January 2021: Sandoz Inc. Approved is not the same as on sale: patents, a settlement or the company’s own plans can still hold a launch.
When does the Ferabright patent expire?
No patents are listed for Ferabright in the FDA Orange Book. Why that month: FDA gives new drugs a protected period, for example for a rare-disease use. It ends then.
Changes to This Projection
- First generic expected October 2032 on this month’s schedule. A line is added here whenever a monthly update moves the month, the reason or how sure it is.
Every change to the expected month is logged here with the month we saw it.
Also Going Generic
- RydaptMidostaurin2026 to 2027
- AirsupraAlbuterol Sulfate and BudesonideMay 2030
- NoctivaDesmopressin AcetateJune 2030
- DescovyEmtricitabine and Tenofovir Alafenamide FumarateOctober 2031
- InlexzoGemcitabine HydrochlorideNovember 2038
- VeppanuVepdegestrantMay 2040
About Ferabright
- Generic name ferumoxytol
- How it is taken Into a vein (IV)
- Company Azurity Pharmaceuticals Inc
- Hard to copy Inhalers, injectables, patches and other hard-to-copy products. Fewer companies attempt them and dates slip more often.
- More drugs Brand-name drugs starting with F
- Have a question? A pharmacist answers, free. Ask about Ferabright
Sources. The expected month: FDA Paragraph IV Patent Certifications list, federal court records, company announcements and securities filings (settlement dates, launch plans, sales). The record on this page: FDA Orange Book, FDA NDC Directory, FDA, Generic Competition and Drug Prices (2019). Updated October 9, 2026. Information, not medical advice.